The store will not work correctly when cookies are disabled.
4-(4-(2,5-dimethylphenyl)-3-(methoxycarbonyl)-5-methylthiophen-2-ylamino)-4-oxobut-2-enoic acid
ID: ALA4786630
PubChem CID: 1002591
Max Phase: Preclinical
Molecular Formula: C19H19NO5S
Molecular Weight: 373.43
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COC(=O)c1c(NC(=O)/C=C/C(=O)O)sc(C)c1-c1cc(C)ccc1C
Standard InChI: InChI=1S/C19H19NO5S/c1-10-5-6-11(2)13(9-10)16-12(3)26-18(17(16)19(24)25-4)20-14(21)7-8-15(22)23/h5-9H,1-4H3,(H,20,21)(H,22,23)/b8-7+
Standard InChI Key: ZKYIULIRTLREAV-BQYQJAHWSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
3.1449 -8.6012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9621 -8.6012 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.2165 -7.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5535 -7.3423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8948 -7.8245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6637 -9.2617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5509 -6.5244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2580 -6.1147 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8426 -6.1169 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2568 -5.2975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1197 -7.5749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9505 -6.7743 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1740 -6.5220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5660 -7.0693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7397 -7.8722 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5160 -8.1207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6885 -8.9195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0041 -5.7226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9940 -7.5730 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6006 -8.1207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3781 -7.8692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4295 -8.9198 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9846 -8.4169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7622 -8.1654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3704 -8.7118 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.9349 -7.3650 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
1 6 1 0
7 8 1 0
7 9 2 0
4 7 1 0
8 10 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 11 1 0
16 17 1 0
13 18 1 0
3 19 1 0
19 20 1 0
20 21 1 0
20 22 2 0
21 23 2 0
23 24 1 0
24 25 1 0
24 26 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 373.43 | Molecular Weight (Monoisotopic): 373.0984 | AlogP: 3.71 | #Rotatable Bonds: 5 |
Polar Surface Area: 92.70 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 2.79 | CX Basic pKa: ┄ | CX LogP: 5.31 | CX LogD: 1.82 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.62 | Np Likeness Score: -0.78 |
References
1. Hou X,Sun JP,Ge L,Liang X,Li K,Zhang Y,Fang H. (2020) Inhibition of striatal-enriched protein tyrosine phosphatase by targeting computationally revealed cryptic pockets., 190 [PMID:32078861] [10.1016/j.ejmech.2020.112131] |